Insiders Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 01:37:31 12/05/26 am AEST			5-day change	1st Jan Change
37.08 ^EUR	+0.27%		-2.55%	+0.19%

11/05	Weekly Earnings Calendar
08/05	BAYER AG : UBS maintains a Buy rating	ZD

Insiders

01/04	Bayer AG Announces Appointment of Nelson Ambrogio as President of U.S. Pharmaceuticals, Effective May 1, 2026	CI
04/03	Bayer Net Loss Widens on Weedkiller Litigation Charges -- Update	DJ
04/03	Bayer Net Loss Widens on Weedkiller Litigation Charges	DJ
23/02	After Takeover: Covestro CEO Announces Departure	DP
23/02	Covestro CEO Steilemann Announces Departure Following Adnoc Takeover	RE
24/11	Bayer shares up more than 8% on revived fortunes for blood thinner	RE
07/11	Bayer AG Appoints Judith Hartmann to the Board of Management, Effective March 1, 2026	CI
07/11	Bayer Names Successor to Outgoing CFO	MT
07/11	Bayer AG - Dr. Judith Hartmann to become new chief financial officer of Bayer AG	RE
17/07/25	Bayer Extends CEO Anderson's Contract Until 2029	RE
17/07/25	Bayer extends contract of CEO until March 2029	RE
17/07/25	Bayer extends contract of CEO until March 2029	RE
17/07/25	Bayer supervisory board extends contract of CEO Bill Anderson	RE
01/07/25	Bayer Announces Executive Changes for North America	CI
04/06/25	Bayer: launches tomatoes resistant to the ToBRV virus
29/04/25	Guru Ramamurthy Appointed As New CFO For Bayer's Crop Science Division	RE
29/04/25	Bayer Announces Changes to CFO for Crop Science Division, Effective July 1, 2025	CI
25/03/25	Bayer Announces Management Changes, Effective April 15, 2025	CI
24/03/25	Bayer: new R&D manager for agrochemicals
23/01/25	Bayer Teams Up with Pula Foundation to Insure Smallholder Farmers in Africa, Asia	MT
30/08/24	Bayer: new CEO for Bayer HealthCare in France
06/08/24	Bayer's operating profit hit by weak agrochemicals demand	RE
06/05/24	Singtel-owned Optus names broadband network boss Stephen Rue as new CEO	RE
11/04/24	Bayer: new Chief Scientific Officer at AskBio
02/04/24	Bayer Appoints Sue Ann Pentecost as Head of U.S. Pharmaceutical Communications	CI